UIM
HZNP

USS Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

USS Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,726
Closed -$6.56M – 583
2023
Q3 		$6.56M Buy
56,726
+4,267
+8% +$458K 0.07% 286
2023
Q2 		$5.4M Hold
52,459
– – 0.06% 332
2023
Q1 		$5.73M Sell
52,459
-1,403
-3% -$155K 0.08% 295
2022
Q4 		$6.13M Hold
53,862
– – 0.09% 282
2022
Q3 		$3.33M Sell
53,862
-5,255
-9% -$367K 0.05% 395
2022
Q2 		$4.72M Sell
59,117
-3,059
-5% -$290K 0.05% 389
2022
Q1 		$6.54M Buy
62,176
+15,169
+32% +$1.48M 0.05% 368
2021
Q4 		$5.07M Hold
47,007
– – 0.04% 437
2021
Q3 		$5.15M Buy
+47,007
New +$4.88M 0.04% 421

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

USS Investment Management's HZNP Position: Q4 2023 in Review

USS Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 56,726 shares — an estimated $6.56M sold.

USS Investment Management first reported a position in HZNP in Q3 2021 and held it in 9 quarters. The position peaked at $6.56M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • USS Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • USS Investment Management sold 56,726 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.56M.
  • USS Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 9 quarters.
  • USS Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.56M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on USS Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.